Back to Search Start Over

Renal Cell Cancer Treated with a Single-Edged Sword

Authors :
Emerson Lim
Edward P. Gelmann
Source :
Cell Reports, Vol 3, Iss 2, Pp 275-276 (2013)
Publication Year :
2013
Publisher :
Elsevier, 2013.

Abstract

Preclinical and early clinical data suggest that antiangiogenic treatments may lead to more aggressive tumors. In this issue of Cell Reports, Blagoev et al. (2013) show that sunitinib, a multikinase inhibitor with antiangiogenic effects, does not worsen the survival of patients with metastatic kidney cancer.

Subjects

Subjects :
Biology (General)
QH301-705.5

Details

Language :
English
ISSN :
22111247
Volume :
3
Issue :
2
Database :
Directory of Open Access Journals
Journal :
Cell Reports
Publication Type :
Academic Journal
Accession number :
edsdoj.1bfabec657948dda33ea4660d983113
Document Type :
article
Full Text :
https://doi.org/10.1016/j.celrep.2013.02.001
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details